Evidence map›Paper›PMID 22556082›Full record

ArticleThe American journal of tropical medicine and hygiene2012

Effect of filarial infection on serum inflammatory and atherogenic biomarkers in coronary artery disease (CURES-121).

Vivekanandhan Aravindhan, Viswanathan Mohan, Jayagopi Surendar, Maradana Muralidhara Rao, Rajamanickam Anuradha, Mohan Deepa, Subash Babu

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Metabolic Consequences of Concomitant Strongyloides stercoralis Infection in Patients With Type 2 Diabetes Mellitus.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Vivekanandhan AravindhanLaboratory of Molecular Immunology, AU-KBC Research Centre, Anna University, Chennai, India. cvaravindhan@yahoo.co.uk
Viswanathan Mohan
Jayagopi Surendar
Maradana Muralidhara Rao
Rajamanickam Anuradha
Mohan Deepa
Subash Babu
Anna University, Chennai · IN

Funding

India International Center for Excellence in ResearchZIAAI001065 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI NUTMAN, THOMAS · 2009 to 2025
$19.0M
Intramural NIH HHS
6 · The paper itself

Abstract

Helminth infections can potentially confer protection against metabolic disorders, possibly through immunomodulation. In this study, the baseline prevalence of lymphatic filariasis (LF) among subjects without (N = 236) and with (N = 217) coronary artery disease (CAD) was examined as part of the Chennai Urban Rural Epidemiological Study (CURES). The prevalence of LF was not significantly different between CAD(-) and CAD(+) subjects. The LF antigen load and antibody levels indicated comparable levels of infection and exposure between the groups. Within the CAD group, LF(+) and LF(-) subjects had no significant difference in the intimal medial thickness and high-sensitivity C-reactive protein values. However, LF infection was associated with augmented levels of tumor necrosis factor-α and interleukin-6 among CAD(+) subjects. The LF infection had no effect on serum adipocytokine profile. In conclusion, unlike type-2 diabetes, there is no association between the prevalence of LF and CAD and also no evidence of protective immunomodulation of LF infection on CAD in the Asian Indian population.

Indexed as

AdultAgedBiomarkersCoronary Artery DiseaseC-Reactive ProteinElephantiasis, FilarialEpidemiologic StudiesFemaleHumansIndiaInflammationInterleukin-6MaleMiddle AgedPrevalenceRisk FactorsBiomarkersC-Reactive ProteinInterleukin-6Tumor Necrosis Factor-alpha

Identifiers

PMID22556082
PMCPMC3335688
OpenAlexW1980670749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.